Overview

Sodium bicarbonate (NaHCO₃), commonly known as baking soda, is one of the most extensively researched ergogenic aids in sports science. Its performance-enhancing mechanism is straightforward: during high-intensity anaerobic exercise, rapid glycolysis produces lactate and hydrogen ions (H⁺) that accumulate intracellularly, lowering muscle pH and contributing to fatigue, impaired calcium handling, and reduced glycolytic enzyme activity. Sodium bicarbonate ingestion raises blood bicarbonate concentration and pH (inducing mild metabolic alkalosis), increasing the extracellular buffering capacity and enhancing the efflux of H⁺ ions from working muscle cells via monocarboxylate transporters and the sodium-hydrogen exchanger. This delays the onset of intracellular acidosis and extends time to fatigue.

Meta-analyses consistently demonstrate that sodium bicarbonate supplementation (typically 0.2-0.3 g/kg body weight taken 60-120 minutes before exercise) improves performance in high-intensity activities lasting 1-7 minutes by approximately 2-3%. Benefits are most robust in repeated sprint protocols, 400m-1500m running, rowing, swimming events of 100-400m, and high-intensity interval training. The ergogenic effect extends to resistance exercise, where sodium bicarbonate may increase total training volume at high intensities. These performance improvements, while seemingly modest in percentage terms, are highly meaningful in competitive sport where margins of victory are razor-thin. Sodium bicarbonate also shows promise in team sports requiring repeated high-intensity efforts such as judo, boxing, and CrossFit-style competitions.

The primary limitation of sodium bicarbonate supplementation is gastrointestinal distress, which affects 30-50% of users and can include nausea, bloating, abdominal cramping, and diarrhea. Strategies to mitigate GI issues include serial loading protocols (smaller doses over 3-5 days), taking the dose with a carbohydrate-rich meal, using enteric-coated capsules, or splitting the acute dose into multiple smaller servings over 30-60 minutes. Beta-alanine provides complementary intracellular buffering through carnosine synthesis, and the two are often stacked for additive pH-buffering effects across both intracellular and extracellular compartments. Sodium bicarbonate is not banned by WADA and remains one of the most cost-effective legal ergogenic supplements available.

Mechanism of Action

Sodium bicarbonate (NaHCO3) is the most widely used alkalinizing agent, functioning through the body's principal extracellular buffer system. Upon administration, it dissociates completely into sodium (Na+) and bicarbonate (HCO3-) ions. The bicarbonate ion directly neutralizes excess hydrogen ions (H+) in a simple acid-base reaction: HCO3- + H+ -> H2CO3 (carbonic acid). Carbonic anhydrase then rapidly catalyzes the dehydration of carbonic acid to CO2 and H2O. The generated CO2 is eliminated through pulmonary ventilation, effectively removing the acid load from the body. This reaction shifts the Henderson-Hasselbalch equilibrium toward a higher pH.

In the kidneys, administered bicarbonate increases the filtered bicarbonate load. Under normal conditions, approximately 80-90% of filtered bicarbonate is reabsorbed in the proximal tubule via Na+/H+ exchangers (NHE3) and basolateral Na+/HCO3- cotransporters (NBCe1). When plasma bicarbonate exceeds the renal threshold (approximately 24-26 mEq/L), excess bicarbonate is excreted in urine, producing urinary alkalinization. This urinary alkalinization is therapeutically exploited to enhance excretion of weak acids (e.g., salicylate, methotrexate) through ion trapping and to prevent uric acid and cystine crystallization.

At the cellular level, correction of acidosis by sodium bicarbonate restores optimal pH for enzymatic function, improves cardiac contractility (which is depressed in severe acidosis), and reverses acidosis-induced vasodilation. In exercise physiology, sodium bicarbonate pre-loading increases extracellular buffering capacity, enhancing the efflux of H+ and lactate from exercising muscle via monocarboxylate transporters (MCTs), thereby delaying the onset of intracellular acidosis and muscular fatigue.

Research

Safety Profile

Safety Profile: Sodium Bicarbonate

Common Side Effects

• Gastrointestinal symptoms: bloating, flatulence, belching (CO2 production upon reaction with stomach acid), abdominal distension, and nausea
• Increased thirst due to sodium load
• Mild peripheral edema (water retention from sodium)
• Frequent urination (alkaline diuresis)
• Altered taste (salty, alkaline)

Serious Adverse Effects

• Metabolic alkalosis: excessive intake raises blood pH above 7.45; symptoms include confusion, muscle twitching, hand tremor, nausea, and in severe cases cardiac arrhythmias and seizures; risk increases with renal impairment
• Sodium overload: each gram contains ~274 mg sodium; chronic high intake can cause hypertension, fluid retention, and heart failure exacerbation; a teaspoon (~4.6 g) contains ~1260 mg sodium
• Hypokalemia: alkalosis drives potassium into cells; dangerously low serum potassium can cause cardiac arrhythmias and muscle weakness
• Hypocalcemia: alkalosis increases protein binding of calcium, reducing ionized calcium; symptoms include paresthesias, tetany, and seizures
• Gastric rupture: extremely rare but reported; rapid CO2 generation from large doses on a full stomach with impaired gastric outlet can cause gastric distension and perforation
• Milk-alkali syndrome: combining sodium bicarbonate with high calcium intake (dairy or supplements) can cause hypercalcemia, renal insufficiency, and metabolic alkalosis

Contraindications

• Metabolic or respiratory alkalosis
• Hypocalcemia (bicarbonate will worsen ionized calcium reduction)
• Hypokalemia (alkalosis exacerbates potassium shifts)
• Severe heart failure or sodium-restricted diets
• Severe renal insufficiency (inability to excrete bicarbonate load)
• GI obstruction or perforation risk
• Concurrent high-calcium intake (milk-alkali syndrome risk)

Drug Interactions

• Virtually all oral medications: sodium bicarbonate raises gastric pH, which affects dissolution, solubility, and absorption of many drugs; separate by 1–2 hours
• Aspirin and salicylates: alkaline urine increases salicylate excretion; may reduce aspirin efficacy
• Lithium: alkaline urine increases lithium clearance; may reduce therapeutic levels
• Methotrexate: urinary alkalinization increases methotrexate excretion; used therapeutically in high-dose MTX protocols but can reduce efficacy of standard dosing
• Tetracyclines and fluoroquinolones: reduced absorption in alkaline gastric environment
• Ketoconazole and itraconazole: require acidic gastric pH for absorption; efficacy reduced by bicarbonate
• Amphetamines and pseudoephedrine: alkaline urine reduces excretion; may increase drug effects and toxicity
• Enteric-coated medications: premature dissolution possible if gastric pH rises above enteric coating threshold

Population-Specific Considerations

• Athletes: 200–300 mg/kg taken 60–90 minutes before exercise is an evidence-based ergogenic aid for high-intensity performance; GI distress is the primary limiting factor; serial dosing protocols may improve tolerability
• Antacid use: FDA-approved OTC antacid; use for occasional heartburn only; chronic daily use risks metabolic alkalosis and sodium overload
• Heart failure / hypertension: sodium content makes this a poor antacid choice; use alternative agents (calcium carbonate, PPIs, H2 blockers)
• Elderly: heightened risk of metabolic alkalosis, hypokalemia, and sodium overload; renal function decline compounds risks
• Pregnancy: occasional antacid use is acceptable; chronic high-dose use risks metabolic alkalosis affecting fetal acid-base balance
• Kidney disease: severely impaired bicarbonate excretion; use only under nephrologist supervision; paradoxically, controlled low-dose bicarbonate supplementation is used therapeutically to manage metabolic acidosis in CKD

Pharmacokinetic Profile